Literature DB >> 19795152

Predictors and prevalence of low bone mineral density in fully ambulatory persons with multiple sclerosis.

Linn Hofsøy Steffensen1, Svein Ivar Mellgren, Margitta T Kampman.   

Abstract

The implications of having multiple sclerosis (MS) for bone health are incompletely understood. The aim of this population-based study is to identify past and current exposures that are associated with bone mass in fully ambulatory persons with MS up to age 50 years and to determine the prevalence of low bone mineral density (BMD) in this group. We measured BMD (hips, lumbar spine, forearms), physical function, BMI, and serum 25(OH) vitamin D in 55 women and 25 men with MS. Patients provided information on demographic variables and medical history, as well as past and current vitamin D and calcium intake, physical activity, and lifestyle habits. In regression analyses, BMD levels were adjusted for age, sex, and BMI. At the femoral neck, strong associations were found for walking distance (beta = 0.152; P < 0.001) and age (beta = -0.004; P = 0.003), and less certain associations for male sex (beta = 0.055; P = 0.014) and 10-foot timed tandem walk (-0.008; P = 0.013). At the lumbar spine, walking distance (beta = 0.013; P = 0.006) and possibly physical activity growing up (beta = 0.035; P = 0.028) and male sex (beta = -0.057; P = 0.042), were associated with BMD. At the ultradistal radius, strength of grip (beta = 0.001; P = 0.002), and, less certainly, summer outdoor activities age 16-20 (beta = 0.021; P = 0.009), and age at MS onset (beta = 0.002; P = 0.036) were associated with BMD. Low BMD (z score < or = -2) was present in 19 out of 80 patients. This study shows that MS-related variables as well as past exposures differentially affect BMD at three clinically important skeletal sites. Low BMD is prevalent in these young patients. Bone health should receive attention in care for persons with MS.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19795152     DOI: 10.1007/s00415-009-5337-6

Source DB:  PubMed          Journal:  J Neurol        ISSN: 0340-5354            Impact factor:   4.849


  36 in total

1.  Positive association between 25-hydroxy vitamin D levels and bone mineral density: a population-based study of younger and older adults.

Authors:  Heike A Bischoff-Ferrari; Thomas Dietrich; E John Orav; Bess Dawson-Hughes
Journal:  Am J Med       Date:  2004-05-01       Impact factor: 4.965

2.  Validity and reliability of adult recall of past sun exposure in a case-control study of multiple sclerosis.

Authors:  I A F van der Mei; L Blizzard; A-L Ponsonby; T Dwyer
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2006-08       Impact factor: 4.254

Review 3.  Osteoporosis and its management.

Authors:  Kenneth E S Poole; Juliet E Compston
Journal:  BMJ       Date:  2006-12-16

4.  Predictive value of grip strength for bone mineral density in males: site specific or systemic?

Authors:  Gülümser Aydin; Ebru Atalar; Işik Keleş; Aliye Tosun; Gülfer Zöğ; Hatice Keleş; Sevim Orkun
Journal:  Rheumatol Int       Date:  2006-08-25       Impact factor: 2.631

5.  Outdoor activities and diet in childhood and adolescence relate to MS risk above the Arctic Circle.

Authors:  M T Kampman; T Wilsgaard; S I Mellgren
Journal:  J Neurol       Date:  2007-03-21       Impact factor: 4.849

Review 6.  Vitamin D deficiency.

Authors:  Michael F Holick
Journal:  N Engl J Med       Date:  2007-07-19       Impact factor: 91.245

7.  Comparison of diet measures from a food-frequency questionnaire with measures from repeated 24-hour dietary recalls. The Norwegian Women and Cancer Study.

Authors:  Anette Hjartåker; Lene Frost Andersen; Eiliv Lund
Journal:  Public Health Nutr       Date:  2007-03-15       Impact factor: 4.022

8.  Longitudinal changes in forearm bone mineral density in women and men aged 25-44 years: the Tromsø study: a population-based study.

Authors:  N Emaus; G K R Berntsen; R M Joakimsen; V Fønnebø
Journal:  Am J Epidemiol       Date:  2005-08-24       Impact factor: 4.897

9.  Markers of bone remodeling predict rate of bone loss in multiple sclerosis patients treated with low dose glucocorticoids.

Authors:  Jan J Stepan; Eva Havrdová; Michaela Týblová; Dana Horáková; Veronika Tichá; Iveta Nováková; Vít Zikán
Journal:  Clin Chim Acta       Date:  2004-10       Impact factor: 3.786

10.  Bone health in ambulatory individuals with multiple sclerosis: impact of physical activity, glucocorticoid use, and body composition.

Authors:  Mina C Mojtahedi; Erin M Snook; Robert W Motl; Ellen M Evans
Journal:  J Rehabil Res Dev       Date:  2008
View more
  14 in total

1.  Bone turnover and metabolism in patients with early multiple sclerosis and prevalent bone mass deficit: a population-based case-control study.

Authors:  Stine Marit Moen; Elisabeth Gulowsen Celius; Leiv Sandvik; Magritt Brustad; Lars Nordsletten; Erik Fink Eriksen; Trygve Holmøy
Journal:  PLoS One       Date:  2012-09-19       Impact factor: 3.240

Review 2.  Bone health in multiple sclerosis.

Authors:  J C Gibson; G D Summers
Journal:  Osteoporos Int       Date:  2011-05-21       Impact factor: 4.507

3.  Bone mineral density in ambulatory patients with multiple sclerosis.

Authors:  Chrissa Sioka; Stylianos Papakonstantinou; Andreas Fotopoulos; Yiannis Alamanos; Athanasia Georgiou; Sofia Tsouli; Sygliti-Henrietta Pelidou; Athanassios P Kyritsis; John Kalef-Ezra
Journal:  Neurol Sci       Date:  2011-05-18       Impact factor: 3.307

Review 4.  Risk Factors, Epidemiology and Treatment Strategies for Metabolic Bone Disease in Patients with Neurological Disease.

Authors:  S Binks; R Dobson
Journal:  Curr Osteoporos Rep       Date:  2016-10       Impact factor: 5.096

5.  Contribution of vitamin D insufficiency to the pathogenesis of multiple sclerosis.

Authors:  Charles Pierrot-Deseilligny; Jean-Claude Souberbielle
Journal:  Ther Adv Neurol Disord       Date:  2013-03       Impact factor: 6.570

6.  Vitamin D receptor Bsm1 polymorphism, calcium metabolism and bone mineral density in patients with multiple sclerosis: a pilot study.

Authors:  Irene Lambrinoudaki; Elias Patikas; George Kaparos; Eleni Armeni; Demetrios Rizos; Pinelopi Thoda; Andreas Alexandrou; Aristidis Antoniou; George Tsivgoulis; Stergios Gatzonis; Constantinos Panoulis; Nikolaos Triantafyllou
Journal:  Neurol Sci       Date:  2012-12-05       Impact factor: 3.307

Review 7.  Osteoporosis and multiple sclerosis: risk factors, pathophysiology, and therapeutic interventions.

Authors:  Sahil Gupta; Irfan Ahsan; Naeem Mahfooz; Noureldin Abdelhamid; Murali Ramanathan; Bianca Weinstock-Guttman
Journal:  CNS Drugs       Date:  2014-08       Impact factor: 5.749

8.  Correlation of circulating omentin-1 with bone mineral density in multiple sclerosis: the crosstalk between bone and adipose tissue.

Authors:  Majid Assadi; Hooman Salimipour; Samad Akbarzadeh; Reza Nemati; Syed Mojtaba Jafari; Afshar Bargahi; Zahra Samani; Mohammad Seyedabadi; Zahra Sanjdideh; Iraj Nabipour
Journal:  PLoS One       Date:  2011-09-15       Impact factor: 3.240

9.  Can vitamin D supplementation prevent bone loss in persons with MS? A placebo-controlled trial.

Authors:  Linn H Steffensen; Lone Jørgensen; Bjørn Straume; Svein Ivar Mellgren; Margitta T Kampman
Journal:  J Neurol       Date:  2011-03-13       Impact factor: 4.849

10.  Effect of high-dose vitamin D3 intake on ambulation, muscular pain and bone mineral density in a woman with multiple sclerosis: a 10-year longitudinal case report.

Authors:  Barbara M van Amerongen; François Feron
Journal:  Int J Mol Sci       Date:  2012-10-19       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.